Loading...
XWARMRC
Market cap101mUSD
Dec 23, Last price  
47.00PLN
1D
-4.08%
1Q
-16.81%
Jan 2017
147.50%
IPO
220.82%
Name

Mercator Medical SA

Chart & Performance

D1W1MN
XWAR:MRC chart
P/E
—
P/S
0.89
EPS
—
Div Yield, %
5.71%
Shrs. gr., 5y
-1.98%
Rev. gr., 5y
2.21%
Revenues
469m
-13.54%
132,171,000147,811,000168,482,000226,593,000263,591,000300,764,000420,410,000540,333,0001,834,174,0001,727,349,000542,512,000469,064,000
Net income
-20m
L-89.69%
7,759,0006,868,00010,019,00010,272,00013,904,0004,927,0007,468,000-2,031,000930,185,000446,865,000-190,786,000-19,676,000
CFO
-86k
L
7,567,0001,922,00012,565,0007,878,00016,614,00023,671,000-8,215,00038,535,000712,469,000503,000,00040,793,000-86,000
Dividend
Jun 29, 20232.5 PLN/sh

Profile

Mercator Medical S.A., together with its subsidiaries, manufactures and distributes disposable medical gloves, dressings, and non-woven fabric products in Europe and internationally. The company offers surgical and protective, sterile examination and protective, and household gloves; glove brackets; and single-use clothing, including caps, masks, gowns, shoe covers, surgical shirts, sleeve protectors, and patient's shirts. It also provides surgical drape sheets; sterile drapes with non-adhesive opening; surgical sets; and accessories, such as apparatus covers, limb protectors, table covers, camera covers, adhesive pockets for surgical instruments, and self-adhesive nonwoven tapes. The company markets its products under the nitrylex, opero, MERCATOR, Ansell, dermagel, santex, comfort, vinylex, iNtouch, ambulance, and ideal brands. It serves beauty; hotels, restaurants, catering, and private cleaning; agri-food; automotive; home and garden; education; and retail industries, as well as medical customers comprising healthcare units, industrial plants, retail chains, and pharmaceutical wholesalers. The company was founded in 1989 and is headquartered in Kraków, Poland. Mercator Medical S.A. operates as a subsidiary of Anabaza RAIF V.C.I.C. Ltd.
URL
https://mercatormedical.eu/
IPO date
Nov 21, 2013
Employees
888
Domiciled in
PL
Incorporated in
PL

Valuation

Title
PLN in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑122014‑12
Income
Revenues
469,064
-13.54%
542,512
-68.59%
1,727,349
-5.82%
Cost of revenue
378,180
516,150
1,105,175
Unusual Expense (Income)
NOPBT
90,884
26,362
622,174
NOPBT Margin
19.38%
4.86%
36.02%
Operating Taxes
19,044
4,571
32,373
Tax Rate
20.95%
17.34%
5.20%
NOPAT
71,840
21,791
589,801
Net income
(19,676)
-89.69%
(190,786)
-142.69%
446,865
-51.96%
Dividends
(23,873)
Dividend yield
6.00%
Proceeds from repurchase of equity
(16,269)
(331,335)
BB yield
4.09%
33.75%
Debt
Debt current
999
932
1,306
Long-term debt
9,671
5,641
8,354
Deferred revenue
150
156
163
Other long-term liabilities
1,610
2,732
2,227
Net debt
(318,198)
(262,474)
(525,740)
Cash flow
Cash from operating activities
(86)
40,793
503,000
CAPEX
(39,067)
(109,654)
(176,750)
Cash from investing activities
33,591
(146,739)
(230,045)
Cash from financing activities
(41,072)
(1,386)
(333,911)
FCF
150,050
87,586
507,648
Balance
Cash
326,860
421,804
535,301
Long term investments
2,008
(152,757)
99
Excess cash
305,415
241,921
449,033
Stockholders' equity
828,971
951,380
1,090,639
Invested Capital
554,531
769,470
673,487
ROIC
10.85%
3.02%
101.11%
ROCE
10.32%
2.58%
55.21%
EV
Common stock shares outstanding
9,584
9,770
10,122
Price
41.50
-15.91%
49.35
-49.12%
97.00
-77.01%
Market cap
397,725
-17.51%
482,171
-50.89%
981,816
-77.91%
EV
77,148
220,189
460,709
EBITDA
113,003
52,033
641,480
EV/EBITDA
0.68
4.23
0.72
Interest
832
331
119
Interest/NOPBT
0.92%
1.26%
0.02%